122 related articles for article (PubMed ID: 23072387)
1. Nanoparticle engineering enhances anticancer efficacy of andrographolide in MCF-7 cells and mice bearing EAC.
Roy P; Das S; Mondal A; Chatterji U; Mukherjee A
Curr Pharm Biotechnol; 2012 Dec; 13(15):2669-81. PubMed ID: 23072387
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
[TBL] [Abstract][Full Text] [Related]
3. Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich's ascites carcinoma bearing mice.
Kumari M; Ray L; Purohit MP; Patnaik S; Pant AB; Shukla Y; Kumar P; Gupta KC
Eur J Pharm Biopharm; 2017 Aug; 117():346-362. PubMed ID: 28499854
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation.
Graverini G; Piazzini V; Landucci E; Pantano D; Nardiello P; Casamenti F; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
Colloids Surf B Biointerfaces; 2018 Jan; 161():302-313. PubMed ID: 29096375
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis Induction and Antimigratory Activity of Andrographolide Analog (3A.1)-Incorporated Self-Assembled Nanoparticles in Cancer Cells.
Kansom T; Sajomsang W; Saeeng R; Charoensuksai P; Opanasopit P; Tonglairoum P
AAPS PharmSciTech; 2018 Oct; 19(7):3123-3133. PubMed ID: 30117042
[TBL] [Abstract][Full Text] [Related]
6. Influence of gold nanoparticle tagged snake venom protein toxin NKCT1 on Ehrlich ascites carcinoma (EAC) and EAC induced solid tumor bearing male albino mice.
Bhowmik T; Saha PP; DasGupta AK; Gomes A
Curr Drug Deliv; 2014; 11(5):652-64. PubMed ID: 24827982
[TBL] [Abstract][Full Text] [Related]
7. Nanofabrication of methylglyoxal with chitosan biopolymer: a potential tool for enhancement of its anticancer effect.
Pal A; Talukdar D; Roy A; Ray S; Mallick A; Mandal C; Ray M
Int J Nanomedicine; 2015; 10():3499-518. PubMed ID: 25999714
[TBL] [Abstract][Full Text] [Related]
8. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide nanoparticles in leishmaniasis: characterization and in vitro evaluations.
Roy P; Das S; Bera T; Mondol S; Mukherjee A
Int J Nanomedicine; 2010 Dec; 5():1113-21. PubMed ID: 21270962
[TBL] [Abstract][Full Text] [Related]
10. Pro-inflammatory macrophage polarization enhances the anti-cancer efficacy of self-assembled galactomannan nanoparticles entrapped with hydrazinocurcumin.
Kumari M; Purohit MP; Pahuja R; Patnaik S; Shukla Y; Kumar P; Gupta KC
Drug Deliv Transl Res; 2019 Dec; 9(6):1159-1188. PubMed ID: 31440985
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and cell cycle arrest induced by andrographolide lead to programmed cell death of MDA-MB-231 breast cancer cell line.
Banerjee M; Chattopadhyay S; Choudhuri T; Bera R; Kumar S; Chakraborty B; Mukherjee SK
J Biomed Sci; 2016 Apr; 23():40. PubMed ID: 27084510
[TBL] [Abstract][Full Text] [Related]
12. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
13. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
Tian X; Yin H; Zhang S; Luo Y; Xu K; Ma P; Sui C; Meng F; Liu Y; Jiang Y; Fang J
Eur J Pharm Biopharm; 2014 Aug; 87(3):445-53. PubMed ID: 24846793
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies.
Parveen R; Ahmad FJ; Iqbal Z; Samim M; Ahmad S
Drug Dev Ind Pharm; 2014 Sep; 40(9):1206-12. PubMed ID: 23826860
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
[TBL] [Abstract][Full Text] [Related]
16. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
17. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
Yang H; Tang C; Yin C
Acta Biomater; 2018 Jun; 73():400-411. PubMed ID: 29660508
[TBL] [Abstract][Full Text] [Related]
18. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
Mahendiran D; Kumar RS; Viswanathan V; Velmurugan D; Rahiman AK
J Biol Inorg Chem; 2017 Oct; 22(7):1109-1122. PubMed ID: 28884428
[TBL] [Abstract][Full Text] [Related]
20. Folic acid and trastuzumab conjugated redox responsive random multiblock copolymeric nanocarriers for breast cancer therapy: In-vitro and in-vivo studies.
Kumar A; Lale SV; Aji Alex MR; Choudhary V; Koul V
Colloids Surf B Biointerfaces; 2017 Jan; 149():369-378. PubMed ID: 27846450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
